Intraoperative Fluid Management Based on Arterial Pulse Pressure Variation During High-Risk Surgery

Principal investigator Dr. Marcel Rezende Lopes, Department of Anesthesia and Critical Care, Santa Casa de Misericórdia de Passos, Passos MG, Brazil, marcelrlopes@uol.com.br

Study design Single centre randomized controlled trial

Investigation centre Department of Anesthesia and Critical Care, Santa Casa de Misericórdia de Passos, Passos MG, Brazil

Inclusion criteria

• medico-surgical pre-operative decision of post-operative ICU admission (because of co-morbidities or/and the surgical procedure)
• age > 18 yr
• elective surgery

Exclusion criteria

• no informed consent
• cardiac arrhythmias
• body mass index > 40
• patients undergoing surgery with an open thorax
• patients undergoing neurosurgery
• enrolment in any other protocol

Ethics committee The study has been approved by the ethical committee of Santa Casa de Misericórdia de Passos (Passos, MG, Brazil).

Informed consent Written informed consent will be required for each patient.

Start date Sept 22, 2005

Finishing date January 23, 2006

Randomisation Randomisation will be done pre-operatively using sealed envelopes. Patients will be assigned to a Control group (group C) or to an Intervention group (group I)

Intraoperative monitoring In group I, a specific multiparameter bedside monitor (DX 2020, Dixtal, Sao Paulo, SP, Brazil) will be utilized to record continuously and simultaneously the ECG, the pulse oximetry signal, the arterial pressure curve and the capnographic signal.

A specific software is uploaded into this monitor, allowing the recognition of respiratory cycles (from the analysis of the capnographic signal) and the automatic calculation and display of ∆PP.

Intervention During the surgical procedure, patients will be managed according to standard of care at Santa Casa de Misericórdia de Passos.

Group C will receive per-operative fluid at the discretion of the anesthetist. Group I will receive additional hydroxyethylstarch 6% (HES) boluses in order to minimize and maintain ∆PP ≤ 10%. During the postoperative period, both groups will be managed by intensivists (in the ICU) and clinicians (in the wards) not involved in the intraoperative management nor in data collection. These individuals will not be informed of patient allocation.

Data collection Over the study period all data will be collected prospectively. Patients will be followed up until hospital discharge.

Data collection prior to surgery Parameters to be recorded before the surgical procedure are presented in table 1.

The body mass index is calculated according to the standard formula (BMI = weight/height2).

Serum creatinine, prothrombin time, hemoglobin, and platelets will be obtained from routine pre-operative biological tests.

Data collection during surgery Parameters to be recorded during the surgical procedure are presented in table 2.

Data collection after surgery Data collection prior to and during surgery will be done by one individual. Data collection after surgery will be done by another individual not aware of patient allocation.

Information and parameters to be collected after surgery are presented in tables 3 and 4.

During the 24h following ICU admission, blood lactate will be measured every 6h and the mean lactate value will be calculated over the first 24h ICU period.

Postoperative infectious, respiratory, cardiovascular, abdominal, hematologic, and renal complications (table 4) will be recorded according to criteria previously used by other investigators (10-11).

Duration of mechanical ventilation, of ICU stay, and of hospital stay, as well as hospital mortality will be recorded too.

Data will be collected systematically at days 1,2, and 5, as well as at ICU discharge, and hospital discharge.

Statistical analysis Data will be analysed comparing patients in group C with those in group I on an intention-to-treat basis.

The primary outcome measure is the duration of postoperative hospital stay. On the basis of our own hospital registry, the mean duration of postoperative hospital stay in group C is a priori estimated at 16 ± 8 days (mean ± SD).

According to previous publications (1,2), we postulated that the mean duration of postoperative hospital stay in group I could be 35% lower.

A sample size of 33 patients in each group was calculated for a 0.05 difference (two sided) with a power of 80% (12).

Secondary outcome measures are the number of post-operative complications per patient, as well as the duration of mechanical ventilation and ICU stay.

Interim analyses and stopping rules An intermediate analysis after the enrolment of the first 33 patients is planed, in order to readjust the population sample size if necessary, or to stop the trial in case a significant reduction in length of hospital stay (primary endpoint) is observed.

Role of funding source Dixtal (Sao Paulo, SP, Brazil) will provide and upload the automatic calculation software in a bedside monitor owned by Santa Casa de Misericórdia de Passos (Passos, MG, Brazil).

Dixtal had no role in the study design, and will have no role in data collection, data analysis, data interpretation, or writing of the report. The corresponding author (Dr F. Michard) will have full access to all data in the study and will have final responsibility for the decision to submit for publication.

Table 1: Patients characteristics before surgery:

• Sex M/F, Age (yr), Weight (kg), Height (cm), BMI (kg/m2), ASA physical status
• Chronic disease: Renal failure requiring dialysis, Renal failure without dialysis, Cirrhosis, Chronic obstructive pulmonary disease, Hypertension, Peripheral vascular disease, Coronary artery disease, Other cardiopathy, Diabetes mellitus, Cerebrovascular disease
• Pre-operative biological tests: Serum creatinine (micromol/l), Prothrombin time (%), Hemoglobin (g/dl), Platelets (/microl)

Table 2: Patients characteristics during surgery:

• Type of surgery: Upper gastro-intestinal, Hepato-biliary, Lower gastro-intestinal, Urology, Other
• Respiratory settings: Tidal volume (mL), Respiratory frequency (/min)
• Physiologic status/START of surgery: Heart rate (/min), Mean arterial pressure (mmHg), SpO2(%), ∆PP (%), Hemoglobin (g/dl)
• Physiologic status/END of surgery: Heart rate (/min), Mean arterial pressure (mmHg), SpO2 (%), ∆PP (%), Hemoglobin (g/dl), Fluid balance, Volume of crystalloid infused (ml), Volume of colloid infused (ml), Volume of red cells infused (ml), Volume of fresh frozen plasma infused (ml), Total volume infused (ml), Total volume infused (ml/kg/h), Duration of surgery (hours)

Table 3: Patients characteristics after surgery:

• ICU admission : Mean arterial pressure (mmHg), Heart rate (bpm), SpO2 (%), Lactate (mmol/l)
• 24 hr after ICU admission: Mean arterial pressure (mmHg), Heart rate (/min), SpO2 (%), Vasoactive support (if yes please indicate name and dosage), Lactate (mmol/l), Mean lactate over 24h (mmol/l)

Table 4: Post-operative complications

• Infection: Pneumonia, Abdominal, Urinary tract, Central venous catheter, Wound
• Respiratory: Pleural effusion, Pneumothorax, Pulmonary embolism, Respiratory support > 24 h, Acute lung injury
• Cardiovascular: Arrhythmia, Hypotension, Acute pulmonary edema, Acute myocardial infarction, Cardiac arrest, Stroke
• Abdominal: Clostridium difficile diarrhoea, Acute bowel obstruction, Upper gastro-intestinal bleed, Anastomotic leak
• Coagulopathy: Platelet count < 100000/microl, Prothrombin time < 50%
• Renal: Urine output < 500 ml/day, Serum creatinine > 170 micromol/l, Dialysis for acute renal failure
• Total number of complications

References

1. Mythen MG, Webb AR. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg 1995; 130:423-29.
2. Sinclair S, James S, Singer M. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: a randomised controlled trial. BMJ 1997; 315:909-12.
3. Venn R, Steele A, Richardson P, et al. Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth 2002; 88:65-71.
4. Gan TJ, Soppitt A, Maroof M, et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology 2002; 97: 820-26.
5. Conway DH, Mayall R, Abdul-Latif MS, et al. Randomized controlled trial investigating the influence of intravenous fluid titration using oesophageal Doppler monitoring during bowel surgery. Anaesthesia 2002; 57:845-49.
6. Wakeling HG, McFall MR, Jenkins CS, et al. Intraoperative oesophageal Doppler guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth 2005; 95:634-42.
7. Noblett SE, Snowden CP, Shenton BK, et al. Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. Br J Surg 2006; 93:1069-76.
8. Lefrant JY, Bruelle P, Aya AG, et al. Training is required to improve the reliability of esophageal Doppler to measure cardiac output in critically ill patients. Intensive Care Med 1998; 24:347-52.
9. Michard F. Changes in arterial pressure during mechanical ventilation. Anesthesiology 2005 ; 103 :419-28.
10. Bennett-Guerrero E, Welsby I, Dunn TJ, et al. The use of a postoperative morbidity survey to evaluate patients with prolonged hospitalization after routine, moderate-risk, elective surgery. Anesth Analg 1999; 89:514-19.
11. Pearse R, Dawson D, Fawcett J, et al. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial. Crit Care 2005; 9:R687-R693.
12. Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet 2005; 365:1348-1353.